Chin Yang Li

429 total citations
13 papers, 306 citations indexed

About

Chin Yang Li is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, Chin Yang Li has authored 13 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 6 papers in Rheumatology and 4 papers in Hematology. Recurrent topics in Chin Yang Li's work include Eosinophilic Disorders and Syndromes (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Chin Yang Li is often cited by papers focused on Eosinophilic Disorders and Syndromes (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Chin Yang Li collaborates with scholars based in United States, Taiwan and Portugal. Chin Yang Li's co-authors include Lung T. Yam, Ayalew Tefferi, Ruben A. Mesa, Larry D. Cripe, Xiaopan Yao, Martin S. Tallman, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe and Chao H. Chan and has published in prestigious journals such as Blood, Cancer and The American Journal of Medicine.

In The Last Decade

Chin Yang Li

13 papers receiving 297 citations

Peers

Chin Yang Li

GENET

HEMAT

RHEUM

MB

IMMUN

U. Wandl Germany

Angela Amendola Italy

Laurence Baranger France

Ute Apfelbeck Austria

Hans Torben Mourits‐Andersen Denmark

J Score United Kingdom

Jonathan Lambert United Kingdom

Liwei Fang China

Ryan J. Stubbins Canada

Shiqiang Qu China

U. Wandl Germany

Chin Yang Li

161 ×0.9

GENET

250 ×1.7

HEMAT

88 ×0.8

RHEUM

33 ×0.3

MB

42 ×0.5

IMMUN

Citations per year, relative to Chin Yang Li Chin Yang Li (= 1×) peers U. Wandl

Countries citing papers authored by Chin Yang Li

Since Specialization

Citations

This map shows the geographic impact of Chin Yang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin Yang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin Yang Li more than expected).

Fields of papers citing papers by Chin Yang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin Yang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin Yang Li. The network helps show where Chin Yang Li may publish in the future.

Co-authorship network of co-authors of Chin Yang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chin Yang Li. A scholar is included among the top collaborators of Chin Yang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin Yang Li. Chin Yang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Mesa, Ruben A., Xiaopan Yao, Larry D. Cripe, et al.. (2010). Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903. Blood. 116(22). 4436–4438. 109 indexed citations

2.

Lim, Ken‐Hong, Ayalew Tefferi, Chin Yang Li, & Animesh Pardanani. (2009). Hypereosinophilia in 357 Consecutive Patients: Disease Spectrum and Clinical and Laboratory Correlates.. Blood. 114(22). 3903–3903. 1 indexed citations

3.

Pardanani, Animesh, Ken‐Hong Lim, Terra L. Lasho, et al.. (2009). Indolent Mastocytosis in 159 Adults: Smoldering but Not Bone Marrow Only Variant Is Prognostically Significant.. Blood. 114(22). 2906–2906. 1 indexed citations

4.

Mesa, Ruben A., Xiaopan Yao, Larry D. Cripe, et al.. (2008). Lenalidomide and Prednisone for Primary and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis (MF): An Eastern Cooperative Oncology Group (ECOG) Phase II Trial.. Blood. 112(11). 1753–1753. 4 indexed citations

5.

Dingli, David, et al.. (2005). Presence of Unfavorable Cytogenetic Abnormalities Is the Strongest Predictor of Poor Survival in Secondary Myelofibrosis.. Blood. 106(11). 2585–2585. 3 indexed citations

6.

Dingli, David, Susan M. Schwager, Ruben A. Mesa, Chin Yang Li, & Ayalew Tefferi. (2005). Prognosis in transplant‐eligible patients with agnogenic myeloid metaplasia. Cancer. 106(3). 623–630. 42 indexed citations

7.

Tefferi, Ayalew, Shireen Sirhan, Terra L. Lasho, et al.. (2005). The Clinical and PRV-1 Expression Phenotype of Wild-Type, Heterozygous, and Homozygous JAK2 V617F in Polycythemia Vera.. Blood. 106(11). 255–255. 4 indexed citations

8.

Okuno, Scott H., Ayalew Tefferi, Curtis A. Hanson, et al.. (1996). Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells.. PubMed. 93(4). 810–2. 28 indexed citations

9.

Beissner, Robert S., et al.. (1992). Permanent Stained Preparations of Synovial Fluid for Detection of Calcium Compounds Using Alizarin Red S. Biotechnic & Histochemistry. 67(1). 14–20. 1 indexed citations

10.

Solberg, Lawrence A., et al.. (1990). A New Murine Monoclonal Antibody for the Diagnosis of Erythroleukemia. American Journal of Clinical Pathology. 93(3). 387–390. 6 indexed citations

11.

Yam, Lung T., Chao H. Chan, & Chin Yang Li. (1986). Hepatic involvement in systemic mast cell disease. The American Journal of Medicine. 80(5). 819–826. 34 indexed citations

12.

Peterson, H. D., et al.. (1985). Primary pulmonary lymphoma. A clinical and immunohistochemical study of six cases. Cancer. 56(4). 805–813. 33 indexed citations

13.

Yam, Lung T., et al.. (1980). Eosinophilia in Systemic Mastocytosis. American Journal of Clinical Pathology. 73(1). 48–54. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact